Oppioidi

PiPTapentadol

Acquista Nortilidina

PiPTapentadol – Wholesale PiPTapentadol

PiPTapentadol is a structural analogue of tapentadol featuring a piperidine-type substitution on the phenylpropylamine scaffold. PiPTapentadol is an opioid analgesic, a Tapentadol derivative with similar effects. This drug acts as an agonist of the μ opioid receptor and a norepinephrine reuptake inhibitor (NRI). This drug is a designer tool for detecting analgesic properties in laboratory conditions.

Prezzo:

PiPTapentadol 5 g 100 $ Aggiungi al carrello

PiPTapentadol 10 g 160 $ Aggiungi al carrello 

PiPTapentadol 50 g 380 $ Aggiungi al carrello Spedizione gratuita!

PiPTapentadol 100 g 600 $ Aggiungi al carrello Spedizione gratuita!

PiPTapentadol 500 g 2000 $ Aggiungi al carrello Spedizione gratuita

PiPTapentadol 1 kg 3500 $ Aggiungi al carrello Spedizione gratuita

 PiPTapentadol – Structural and Pharmacological Overview

Chemical Classification

PiPTapentadol is a synthetic opioid analogue structurally derived from tapentadol, itself a centrally acting analgesic combining μ-opioid receptor agonism with norepinephrine reuptake inhibition (NRI).
In PiPTapentadol, the primary amine group of tapentadol is substituted with a piperidine or piperazine-type moiety, altering its receptor affinity and pharmacokinetic properties.

This modification places PiPTapentadol within the broader arylmethylamine / phenethylamine opioid family, alongside other designer analogues investigated in forensic toxicology and receptor mapping research.

Chemical Features

  • Base structure: Derived from (±)-3-(3-hydroxyphenyl)-N,N-dimethylmethylbutanamine (tapentadol scaffold)
  • Typical substitution: Replacement of the primary amine with piperidine or isopropylpiperidine (PiP) group
  • Functional groups: Phenolic hydroxyl, tertiary amine, secondary alcohol
  • Predicted molecular weight: ~275–310 g/mol (depending on salt form)
  • Likely salt forms: Hydrochloride or fumarate

Pharmacology (Predicted from Structural Analogy)

  1. μ-Opioid Receptor Agonism (MOR):
    The phenolic hydroxyl and basic amine group maintain MOR affinity similar to tapentadol, conferring analgesic and sedative properties in receptor assays.
  2. Norepinephrine Reuptake Inhibition (NRI):
    The extended amine side chain may preserve NRI activity, suggesting a dual mechanism combining opioid and noradrenergic modulation.
  3. Reduced Serotonin Reuptake Affinity:
    Compared to tramadol analogues, PiPTapentadol likely exhibits minimal serotonergic effect.
  4. Expected effects (research observation):
    • Central analgesia (MOR-mediated)
    • Sedation, miosis, respiratory depression (dose-dependent)
    • Elevated norepinephrine tone (mild stimulant-like property at low doses)

Toxicology and Safety Considerations

  • No human pharmacokinetic data are available.
  • As with all novel opioid analogues, PiPTapentadol presents high risk for respiratory depression, CNS depression, and dependence.
  • Cross-tolerance with other opioids is likely but unpredictable.
  • In forensic casework, analogues of tapentadol have been implicated in fatal overdoses when misused.
  • Analytical detection may require LC-MS/MS with specific precursor ion transitions unique to the PiP-substituted moiety.

Forensic and Analytical Use

PiPTapentadol may appear in the context of:

  • Designer opioid screening panels
  • Toxicological reference standard development
  • Structure–activity relationship (SAR) modeling for synthetic analgesics

Legal and Ethical Context

  • Tapentadol is a controlled prescription opioid in most jurisdictions.
  • Its analogues (including PiPTapentadol) are unapproved for medical use and may fall under analogue or NPS control laws.
  • Any handling should comply with local controlled substance regulations and be limited to licensed analytical or academic laboratories.

 Summary

PiPTapentadol is a tapentadol-derived experimental opioid analogue investigated for its unique receptor binding and pharmacological profile. It combines μ-opioid agonism with potential norepinephrine reuptake inhibition, but lacks formal toxicological, safety, or clinical data. Research use is strictly limited to controlled laboratory environments with full compliance to applicable regulations.

PiPTapentadol
PiPTapentadol

 

 

 

 

Sinonimi
  • PiPTapentadol
  • PiPTapentadol HCL
IUPAC    3-(2-methyl-1-(piperidin-1-yl)pentan-3-yl)phenol
Formula    C17H27NO
Peso molecolare    261.41 g/mol
CAS
Aspetto    A neat solid
Purezza    ≥ 98 %

 

-Scegli i tuoi prodotti preferiti da Chems Axis , e ti è garantita un'eccellente qualità al miglior prezzo.

Le buste vengono spedite 24 ore dopo il pagamento.
Tempi di consegna: 3-4 giorni lavorativi.
Velocità di consegna 100% in tutta Europa.

Devi conoscere lo stato legale del prodotto che ordini nel tuo paese.
-Ordinando sul nostro sito web a partire da 250 dollari statunitensi, la consegna è a nostro carico. Il gestore esclude automaticamente le spese di spedizione per gli ordini effettuati su $ 250. 

Best place to buy PiPTapentadol Online | Where to buy PiPTapentadol

PiPTapentadol is a synthetic opioid analogue structurally derived from tapentadol, itself a centrally acting analgesic combining μ-opioid receptor agonism with norepinephrine reuptake inhibition (NRI). In PiPTapentadol, the primary amine group of tapentadol is substituted with a piperidine or piperazine-type moiety, altering its receptor affinity and pharmacokinetic properties. We are happy to answer your questions or provide more information.

amministratore

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *